Chinese Premier Li Keqiang Visits WuXi Headquarters in Shanghai

Chinese Premier Li Keqiang visited WuXi's headquarter in Shanghai on March 28, 2013. The visit was part of the first research tour by the newly elected Chinese Premier since assuming office...

WuXI Global Webinar: “Accelerating Innovation in a Collaborative Biopharma Ecosystem”

Overview New avenues for innovation, productivity and efficiency are vital to bringing new medicines for global, unmet medical needs. Open innovation, open-access platforms, and partnership among industry, academia, non-profits, the venture capital...

“Every Client is a Partner” – ChinaBio® Interview

ChinaBio® recently had a chance to talk with Richard Soll, PhD, Senior Vice President of Integrated Services, Head of Corporate Alliances at WuXi AppTec, China’s largest contract research organization. The subject...

WuXi Presents the 2012 Life Science and Chemistry Awards

WuXi announced the winners of its sixth annual Life Science and Chemistry Awards at a ceremony held on January 20, 2013. Eighteen highly accomplished young scholars were honored after a rigorous and...

WuXi and OMT Expand Human Antibody Development and Commercial Opportunities

In March 2013, WuXi and Open Monoclonal Technology, Inc. (OMT), an innovator in novel transgenic animals for development of human therapeutic antibodies, announced a second agreement that expands WuXi's use of...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

WuXi AppTec Expands Site in the United States for Drug Development...

We are pleased to announce the grand opening of WuXi AppTec's expanded Laboratory Testing Division (LTD) facility in New Jersey. The expansion will double total...